Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tammenoms Bakker Juliet
Relationship:  
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   190,546    

Indirect Shares

   34,191,873      
Direct Value   $5,934,907    

Indirect Value

   $610,325,496      
Total Shares   34,382,419      
Total Value   $616,260,404      


Corcept Therapeutics Inc $3,269,035 Aimmune Therapeutics, Inc. $574,293 Axonics Modulation Technologies, Inc. $235,830 Eargo, Inc. $0 Rxsight, Inc. $1,855,750 Corcept Therapeutics Inc $3,269,035 Aimmune Therapeutics, Inc. $574,293 Axonics Modulation Technologies, Inc. $235,830 Eargo, Inc. $0 Rxsight, Inc. $1,855,750
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    13    

     Stock price went up :
    3   
    12    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   1.5   
   12.0   
     Percentage Gain/Loss :
   8.4%
 1,095.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Corcept Therapeutics Inc CORT 10% Owner 2016-12-15 133,539 2016-12-15 10,956,002    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2014-11-18 28,186    Premium*  
            Aimmune Therapeutics, Inc. AIMT 10% Owner 2018-02-22 16,651 2018-02-22 6,013,134    Premium*  
            Molecular Templates, Inc. MTEM 10% Owner 2018-09-21 0 2020-08-28 3,202,530    Premium*  
            Axonics Modulation Technologies,... AXNX Director 2020-09-18 3,500 2020-09-18 1,956,359    Premium*  
            Venus Concept Inc VERO Director, 10% Owner 2019-11-07 0 2019-11-07 3,666,119    Premium*  
            Eargo, Inc. EAR Director, 10% Owner 2021-05-17 7,016 2021-05-17 3,008    Premium*  
            Tourmaline Bio TRML 10% Owner 2021-05-11 0 2021-05-11 3,220,775    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Rxsight, Inc. RXST 2024-02-14 29,840 2024-02-14 1,548    Premium*  
* Premium Members only  

Records found :    96         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AIMT Aimmune Therapeutics, Inc... 10% Owner   –       –       •   2018-02-22 4 B $32.00 $300,000 D/D 9,375 16,651 2.45 -
AXNX Axonics Modulation Techno... Director   –       •       •   2018-11-02 4 A $0.00 $0 I/I 2,400,000 2,400,000 0 -
AXNX Axonics Modulation Techno... Director   –       •       •   2018-11-02 4 B $15.00 $7,999,995 I/I 533,333 2,933,333 2.25 -
AXNX Axonics Modulation Techno... Director   –       •       •   2018-12-06 4 A $0.00 $0 D/D 2,500 2,500 0 -
AXNX Axonics Modulation Techno...   –       •       •   2019-06-27 4 A $0.00 $0 D/D 1,667 4,167 0 -
AXNX Axonics Modulation Techno...   –       •       •   2019-08-22 4 A $0.00 $0 D/D 5,000 9,167 0 -
AXNX Axonics Modulation Techno... Director   –       •      –    2020-08-10 4 A $0.00 $0 I/I 1,026 1,026 0 -
AXNX Axonics Modulation Techno... Director   –       •      –    2020-08-10 4 D $0.00 $0 I/I (978,000) 1,955,333 0 -
AXNX Axonics Modulation Techno... Director   –       •      –    2020-08-10 4 A $0.00 $0 D/D 2,393 11,560 0 -
AXNX Axonics Modulation Techno... Director   –       •      –    2020-08-14 4 S $43.22 $103,422 D/D (2,393) 9,167 0 %
AXNX Axonics Modulation Techno... Director   –       •      –    2020-09-18 4 S $42.67 $391,119 D/D (9,167) 3,500 0 %
CORT Corcept Therapeutics Inc Director   –       •       •   2008-03-25 3 IO $0.00 $0 D/D 0 3,530,450 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2008-11-11 4 A $1.45 $506,666 D/D 349,425 3,879,875 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2009-02-06 4 B $0.69 $3,189,643 D/D 4,642,857 8,522,732 2.45 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2009-10-16 4 B $1.38 $3,377,623 D/D 2,447,553 10,970,285 2.45 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2010-04-21 4 OE $1.66 $1,422,029 D/D 856,644 11,826,929 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2011-01-21 4 B $3.90 $2,925,000 D/D 750,000 12,576,929 3.92 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2012-03-29 4 OE $2.96 $2,535,666 D/D 856,644 13,433,573 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2014-03-05 4 S $4.01 $286,568 D/D (71,467) 186,325 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2014-03-06 4 S $4.00 $672,530 D/D (168,103) 183,022 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2014-03-07 4 S $4.00 $41,720 D/D (10,430) 182,817 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2014-04-01 4 S $4.28 $1,070,575 D/D (250,000) 177,905 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2014-05-01 4 S $4.12 $674,591 D/D (163,557) 174,691 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2014-05-02 4 S $4.07 $351,979 D/D (86,443) 172,992 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-20 4 OE $2.77 $3,105,056 D/D 1,120,959 13,331,093 0 -
  96  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us